Irene Hiniesto Iñigo
Postdoktor
Publikationer
2026
Cannabidiol inhibits both human KV7.1 and KV7.1/KCNE1 channels through distinct sites
Acta Pharmacologica Sinica
(Artikel i tidskrift)
https://dx.doi.org/10.1038/s41401-025-01742-0
2025
Beneficial action potential duration-shortening effects, but deleterious negative inotropism of IKs-activator docosahexaenoyl glycine in long QT syndrome type 2
Europace, Vol. 27, Artikel euaf168
(Artikel i tidskrift)
https://dx.doi.org/10.1093/europace/euaf168
Modulation of the cardiac Kv7.1/KCNE1 channel by endocannabinoids and derivatives in the context of Long QT Syndrome
(Doktorsavhandling, sammanläggning)
https://dx.doi.org/10.3384/9789181180343
Rescue of loss-of-function long QT syndrome-associated mutations in K<sub>V</sub>7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S)
British Journal of Pharmacology, Vol. 182, s. 2861-2877
(Artikel i tidskrift)
https://dx.doi.org/10.1111/bph.70008
2024
The endocannabinoid ARA-S facilitates the activation of cardiac Kv7.1/KCNE1 channels from different species
CHANNELS, Vol. 18, Artikel 2420651
(Artikel i tidskrift)
https://dx.doi.org/10.1080/19336950.2024.2420651